207 related articles for article (PubMed ID: 25270324)
21. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
Kim SJ; Rosen B; Fan I; Ivanova A; McLaughlin JR; Risch H; Narod SA; Kotsopoulos J
Br J Cancer; 2017 Mar; 116(7):964-971. PubMed ID: 28208158
[TBL] [Abstract][Full Text] [Related]
22. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics.
Odunsi K; Wollman RM; Ambrosone CB; Hutson A; McCann SE; Tammela J; Geisler JP; Miller G; Sellers T; Cliby W; Qian F; Keitz B; Intengan M; Lele S; Alderfer JL
Int J Cancer; 2005 Feb; 113(5):782-8. PubMed ID: 15499633
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer.
Mury D; Woelber L; Jung S; Eulenburg C; Choschzick M; Witzel I; Schwarz J; Jaenicke F; Mahner S
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1131-7. PubMed ID: 21344262
[TBL] [Abstract][Full Text] [Related]
24. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
Li QL; Wang CJ; Qi P; Zhang YX
Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
[TBL] [Abstract][Full Text] [Related]
25. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
Dijkgraaf EM; Santegoets SJ; Reyners AK; Goedemans R; Wouters MC; Kenter GG; van Erkel AR; van Poelgeest MI; Nijman HW; van der Hoeven JJ; Welters MJ; van der Burg SH; Kroep JR
Ann Oncol; 2015 Oct; 26(10):2141-9. PubMed ID: 26216383
[TBL] [Abstract][Full Text] [Related]
26. Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.
Ose J; Poole EM; Schock H; Lehtinen M; Arslan AA; Zeleniuch-Jacquotte A; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Dossus L; Trichopoulou A; Masala G; Onland-Moret NC; Weiderpass E; Duell EJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Trabert B; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Cancer Res; 2017 Jul; 77(14):3951-3960. PubMed ID: 28381542
[TBL] [Abstract][Full Text] [Related]
27. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
Chung HH; Kwon HW; Kang KW; Park NH; Song YS; Chung JK; Kang SB; Kim JW
Ann Surg Oncol; 2012 Jun; 19(6):1966-72. PubMed ID: 22124757
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer.
Zohny SF; Fayed ST
Med Oncol; 2010 Dec; 27(4):1246-53. PubMed ID: 19937162
[TBL] [Abstract][Full Text] [Related]
30. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
Shen Y; Li L
Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
[TBL] [Abstract][Full Text] [Related]
31. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
[TBL] [Abstract][Full Text] [Related]
32. The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study.
Fotopoulou C; Sehouli J; Ewald-Riegler N; de Gregorio N; Reuss A; Richter R; Mahner S; Kommoss F; Schmalfeldt B; Fehm T; Hanker L; Wimberger P; Canzler U; Pfisterer J; Kommoss S; Hauptmann S; du Bois A;
Int J Gynecol Cancer; 2015 Sep; 25(7):1248-52. PubMed ID: 25978292
[TBL] [Abstract][Full Text] [Related]
33. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
Yoffou PH; Edjekouane L; Meunier L; Tremblay A; Provencher DM; Mes-Masson AM; Carmona E
PLoS One; 2011; 6(6):e20705. PubMed ID: 21695196
[TBL] [Abstract][Full Text] [Related]
34. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
35. Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.
Collinson F; Hutchinson M; Craven RA; Cairns DA; Zougman A; Wind TC; Gahir N; Messenger MP; Jackson S; Thompson D; Adusei C; Ledermann JA; Hall G; Jayson GC; Selby PJ; Banks RE
Clin Cancer Res; 2013 Sep; 19(18):5227-39. PubMed ID: 23935036
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.
Nielsen JS; Jakobsen E; Hølund B; Bertelsen K; Jakobsen A
Int J Gynecol Cancer; 2004; 14(6):1086-96. PubMed ID: 15571614
[TBL] [Abstract][Full Text] [Related]
37. Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer.
Yang D; Li H; Sun X; Yang S; Wang K; Liu Z
Sci Rep; 2020 Nov; 10(1):20056. PubMed ID: 33208875
[TBL] [Abstract][Full Text] [Related]
38. Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysis.
Blaakaer J; Høgdall CK; Hørding U; Bennett P; Toftager-Larsen K; Daugaard S; Bock J
Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):21-7. PubMed ID: 8282139
[TBL] [Abstract][Full Text] [Related]
39. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract][Full Text] [Related]
40. Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
Gram IT; Lukanova A; Brill I; Braaten T; Lund E; Lundin E; Overvad K; Tjønneland A; Clavel-Chapelon F; Chabbert-Buffet N; Bamia C; Trichopoulou A; Zylis D; Masala G; Berrino F; Galasso R; Tumino R; Sacerdote C; Gavrilyuk O; Kristiansen S; Rodríguez L; Bonet C; Huerta JM; Barricarte A; Sánchez MJ; Dorronsoro M; Jirström K; Almquist M; Idahl A; Bueno-de-Mesquita HB; Braem M; Onland-Moret C; Tsilidis KK; Allen NE; Fedirko V; Riboli E; Kaaks R
Int J Cancer; 2012 May; 130(9):2204-10. PubMed ID: 21678398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
